Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia

Multidrug-resistant pathogens are becoming more difficult to treat with significantly increasing infection rates. The lack of new antibiotics to combat these strains has led to the resurgence of older antibiotics. This case highlights the first reported use of colistimethate sodium treatment in a 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Lulic-Botica, Mirjana, DeJesus, Lilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653549/
https://www.ncbi.nlm.nih.gov/pubmed/23705076
http://dx.doi.org/10.1055/s-0030-1271217
_version_ 1782269424360751104
author Lulic-Botica, Mirjana
DeJesus, Lilia
author_facet Lulic-Botica, Mirjana
DeJesus, Lilia
author_sort Lulic-Botica, Mirjana
collection PubMed
description Multidrug-resistant pathogens are becoming more difficult to treat with significantly increasing infection rates. The lack of new antibiotics to combat these strains has led to the resurgence of older antibiotics. This case highlights the first reported use of colistimethate sodium treatment in a 23-week gestational-age neonate with multidrug-resistant Acinetobacter baumannii pneumonia who developed acute renal failure and seizures shortly after initiation of treatment.
format Online
Article
Text
id pubmed-3653549
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Thieme Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-36535492013-05-23 Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia Lulic-Botica, Mirjana DeJesus, Lilia AJP Rep Article Multidrug-resistant pathogens are becoming more difficult to treat with significantly increasing infection rates. The lack of new antibiotics to combat these strains has led to the resurgence of older antibiotics. This case highlights the first reported use of colistimethate sodium treatment in a 23-week gestational-age neonate with multidrug-resistant Acinetobacter baumannii pneumonia who developed acute renal failure and seizures shortly after initiation of treatment. Thieme Medical Publishers 2011-01-24 2011-09 /pmc/articles/PMC3653549/ /pubmed/23705076 http://dx.doi.org/10.1055/s-0030-1271217 Text en © Thieme Medical Publishers
spellingShingle Article
Lulic-Botica, Mirjana
DeJesus, Lilia
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title_full Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title_fullStr Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title_full_unstemmed Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title_short Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
title_sort colistin therapy in a 23-week gestational-age neonate with multidrug-resistant acinetobacter baumannii pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653549/
https://www.ncbi.nlm.nih.gov/pubmed/23705076
http://dx.doi.org/10.1055/s-0030-1271217
work_keys_str_mv AT lulicboticamirjana colistintherapyina23weekgestationalageneonatewithmultidrugresistantacinetobacterbaumanniipneumonia
AT dejesuslilia colistintherapyina23weekgestationalageneonatewithmultidrugresistantacinetobacterbaumanniipneumonia

Ejemplares similares